Search
for

    Sort by

    Research 30 of 354

    1. Is sulfonamide group of tamsulosin main factor in the pathophysiology of floppy iris syndrome? Haydarpaşa Numune Hastanesi tıp dergisi · 2018
    2. Trichotillomania and Traction Alopecia InTech eBooks · 2017
    3. Hair loss in psychopharmacology. Annals of Clinical Psychiatry · 2000 · 79 citations
    4. Olanzapine Induced Hair Loss: A Case Report Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · 2012 · 9 citations
    5. Reporting on Adverse Clinical Events Clin-Alert · 2021
    6. Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system Medicine · 2026
    7. Kaleidoscope The British Journal of Psychiatry · 2021
    8. Adverse Cutaneous Reactions to Antipsychotics American Journal of Clinical Dermatology · 2002 · 64 citations
    9. Psychoactive Agents in Dermatology 2000 · 3 citations
    10. Alopecia associated with quetiapine International Clinical Psychopharmacology · 2007 · 19 citations
    11. Psychotropic Treatment of Psychodermatologic Disorders Actas Dermo-Sifiliográficas · 2010 · 3 citations
    12. Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen Journal of the American Academy of Dermatology · 2012
    13. Adverse effects of common medications on male fertility Nature Reviews Urology · 2015 · 77 citations
    14. Psychodermatology Advances in Psychosomatic Medicine · 2015 · 25 citations
    15. Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials Archivio italiano di urologia andrologia · 2021 · 4 citations
    16. Diffuse hair loss associated with hyperprolactinaemia: report of three cases Journal of the European Academy of Dermatology and Venereology · 2014 · 2 citations
    17. Dissolving microneedles: an advanced approach for transdermal drug delivery Journal of Pharmaceutical Research Science & Technology · 2025
    18. Plica Neuropathica as a Presenting Rare Dermatologic Symptom of Schizophrenia Clinical, cosmetic and investigational dermatology · 2023
    19. Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers Pharmaceutics · 2020 · 54 citations
    20. Update on psychodermatological disorders Expert Review of Dermatology · 2010 · 5 citations
    21. Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines Clinical, Cosmetic and Investigational Dermatology · 2017 · 23 citations
    22. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology · 2017 · 213 citations
    23. The Impact of Metformin on Plasma Prolactin Levels in Antipsychotics‐Treated Men With Hyperprolactinemia and Early‐Onset Androgenic Alopecia Clinical Endocrinology · 2025
    24. Efficacy of bergamot: From anti‐inflammatory and anti‐oxidative mechanisms to clinical applications as preventive agent for cardiovascular morbidity, skin diseases, and mood alterations Food science & nutrition · 2019 · 37 citations
    25. Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study Cardiovascular Drugs and Therapy · 2024 · 25 citations
    26. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin The international journal of risk and safety in medicine · 2021 · 8 citations
    27. “Doctor, You Must Examine My Creature Collection!”: A Case Report of Delusional Infestation Cureus · 2022
    28. Psychological interventions in the management of common skin conditions Psychology Research and Behavior Management · 2010 · 41 citations
    29. Trichotillomania: What Do We Know So Far? Skin appendage disorders · 2021 · 8 citations
    30. Potential Medical Uses of Cannabigerol: A Brief Overview Elsevier eBooks · 2017 · 14 citations